Day: March 26, 2025

CALGARY, Alberta, March 26, 2025 (GLOBE NEWSWIRE) — CEMATRIX Corporation (TSX: CEMX) (OTCQB: CTXXF) (“CEMATRIX” or the “Company“) a specialty construction contractor that produces cellular concrete solutions on site and is a leading manufacturer and supplier of cellular concrete in North America announced the release of its consolidated financial results for the quarter and year ended December 31, 2024. “We are proud of our achievements this year, which represent the second-best financial performance in the Company’s history,” said Randy Boomhour, President and CEO of CEMATRIX. “The timing of when our scopes of work start within large projects has a material and significant impact on our financial results. These delays are always out of our control. The delayed start of several key projects in 2024 materially...

In-Person FDA Meeting Scheduled for April 2; New Drug Application Submission Targeted for Mid-2025$17.5 million increase in Working Capital; Cash Runway Extending into Q4, Well Beyond Target Date for NDA Submission KANSAS CITY, Kan., March 26, 2025 (GLOBE NEWSWIRE) — Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, today announced its financial results for the twelve months ended December 31, 2024, and provided a clinical and business update. Highlights include the announcement of safety results from Cingulate’s final Phase 3 trials for lead ADHD asset CTx-1301 (dexmethylphenidate), and confirmation of a scheduled in-person Pre-NDA meeting...

VANCOUVER, British Columbia, March 26, 2025 (GLOBE NEWSWIRE) — Imperial Metals Corporation (the “Company”) (TSX:III) reports financial results for its fiscal year ended December 31, 2024. “Operationally, the 2024 year was aligned with guidance. Copper production was higher at Mount Polley driven largely by higher through-put and copper grades, and both copper and gold production were higher at Red Chris due to higher copper and gold grades,“ said Brian Kynoch, President. “Consolidated production totalled 61,296,423 pounds copper and 57,051 ounces gold. The solid operational results along with higher metal prices helped drive strong financial results. The Company achieved record revenue of $494.4 million. In addition, adjusted EBITDA totalled $209.9 million and cash earnings totalled $211.2 million.” “Looking forward, we expect...

Q4 2024 Revenue of $30.3 million Q4 2024 Net loss of $26.4 million, which included a non-cash impairment loss of $18.9 million Q4 2024 Adjusted EBITDA of $0 millionAll results are reported in United States dollars ($) unless otherwise indicated. LAS VEGAS, March 26, 2025 (GLOBE NEWSWIRE) — Planet 13 Holdings Inc. (CSE: PLTH) (OTCQX: PLNH) (“Planet 13” or the “Company”), a leading vertically-integrated cannabis company, today announced its financial results for the three-month and twelve-month periods ended December 31, 2024. Planet 13’s financial statements are prepared in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”). “In 2024, despite industry-wide price compression, we remained disciplined in executing our key priorities—expanding our retail footprint, scaling operations, and strengthening our product...

SUNNYVALE, Calif., March 26, 2025 (GLOBE NEWSWIRE) — BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported financial results for the year ended December 31, 2024 and filed its annual report on Form 10-K with the Securities and Exchange Commission. The Company will host a corporate update conference call on Monday, March 31, 2025 at 4:30 PM ET following its presentation of results from the CardiAMP HF Trial at the Late-Breaking Clinical Trials symposium at the American College of Cardiology 2025 Scientific Sessions in Chicago (see dial-in information below). Recent Business Highlights CardiAMP® autologous cell therapy in ischemic heart failure of reduced ejection fraction (BCDA-01)In the fourth quarter of 2024, we had a consultation...

Fourth quarter revenue increased 58% to a record $12.6 million Full Year 2024 revenue increased 40% to a record $52.3 million ROMEOVILLE, Ill., March 26, 2025 (GLOBE NEWSWIRE) — Solésence, Inc. (OTCQB: NANX), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced financial results for the fourth quarter and year ended December 31, 2024.    Recent Highlights and AccomplishmentsCompany rebranded as Solésence, Inc., marking a new era of innovation, self-expression, and inclusivity in skin health. The move reflects the success of its consumer products strategy, fueled by its suite of transformative skin health technologies, including award-winning Kleair™. Solésence launched a new investor relations website designed to provide current and prospective investors with...

SAN JOSE, Calif., March 26, 2025 (GLOBE NEWSWIRE) — Firsthand Technology Value Fund, Inc. (OTCQB: SVVC) (the “Fund”), a publicly traded venture capital fund that invests in technology and cleantech companies, announced today its financial results for the year ended December 31, 2024. As of December 31, 2024, the Fund’s net assets were approximately $1.1 million, or $0.15 per share, compared with net assets of approximately $1.5 million, or $0.22 per share as of September 30, 2024. As of December 31, 2024, the Fund’s portfolio included public and private securities valued at approximately $1.1 million, or $0.15 per share, which includes approximately $0.11 per share in cash and cash equivalents. Portfolio Summary (as of 12/31/24)Investment   Fair Value1, Fair Value per Share1,2Equity/Debt Investments $ 0.32 million   $ 0.05Cash/Cash...